Completed OBSERVATIONAL NCT02856282

Drug Utilization Study for Pirinase Hayfever Relief

Drug Utilization Study for Pirinase Hayfever Relief for Adults 0.05% Nasal Spray

Sponsor: GlaxoSmithKline

Interventions Pirinase Hayfever Relief for Adults 0.05% Nasal Spray

Updated 8 times since 2017 Last updated: Mar 29, 2019 Started: Feb 15, 2016 Primary completion: Mar 31, 2018 Completion: Mar 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Rhinitis, Allergic, Seasonal and is currently completed. GlaxoSmithKline leads this study, which shows 8 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jul 2019 — Jan 2021 [monthly]

Completed
Oct 2018 — Jul 2019 [monthly]

Completed

Status: Active Not Recruiting → Completed

▶ Show 3 earlier versions

Jun 2018 — Oct 2018 [monthly]

Active Not Recruiting
Apr 2018 — Jun 2018 [monthly]

Active Not Recruiting

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Active Not Recruiting NA

First recorded

Feb 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

GlaxoSmithKline

Data source: GlaxoSmithKline

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brentford, United Kingdom